IL6 and acute myeloid leukemia: In addition, MSPCs isolated from primary human AML BM samples demonstrated significantly reduced MCP1 levels, and a trend towards lower IL6 and granulocyte macrophage colony-stimulating factor levels, consistent with the view that the leukemic BM microenvironment has a diminished capacity to support normal SCs and hematopoiesis [33,324].